Publikationen von Sylvia Streit

Wimmer, E.; Ihrler, S.; Gires, O.; Streit, S.; Issing, W.; Bergmann, C.: Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas. World Journal of Clinical Oncology 10 (3), S. 136 - 148 (2019)

Roidl, A.; Foo, P.; Wong, W.; Mann, C.; Bechtold, S.; Berger, H. J.; Streit, S.; Ruhe, J. E.; Hart, S.; Ullrich, A. et al.; Ho, H. K.: The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells. Oncogene 29 (10), S. 1543 - 1552 (2010)

Seitzer, N.; Mayr, T.; Streit, S.; Ullrich, A.: A Single Nucleotide Change in the Mouse Genome Accelerates Breast Cancer Progression. Cancer Research 70 (2), S. 802 - 812 (2010)

Ho, H. K.; Pok, S.; Streit, S.; Ruhe, J. E.; Hart, S.; Lim, K. S.; Loo, H. L.; Aung, M. O.; Lim, S. G.; Ullrich, A.: Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. Journal of Hepatology 50 (1), S. 118 - 127 (2009)

Ruhe, J. E.; Streit, S.; Hart, S.; Wong, C. H.; Specht, K.; Knyazev, P.; Knyazeva, T.; Tay, L. S.; Loo, H. L.; Foo, P. et al.; Wong, W.; Pok, S.; Lim, S. J.; Ong, H.; Luo, M.; Ho, H. V.; Peng, K.; Lee, T. C.; Bezler, M.; Mann, C.; Gaertner, S.; Hoefler, H.; Iacobelli, S.; Peter, S.; Tay, A.; Brenner, S.; Venkatesh, B.; Ullrich, A.: Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines. Cancer Research 67 (23), S. 11368 - 11376 (2007)

Streit, S.; Ruhe, J. E.; Knyazev, P.; Knyazeva, T.; Iacobelli, S.; Peter, S.; Hoefler, H.; Ullrich, A.: PTP-PEST phosphatase variations in human cancer. Cancer Genetics and Cytogenetics 170 (1), S. 48 - 53 (2006)

Ruhe, J. E.; Streit, S.; Hart, S.; Ullrich, A.: EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing. Cellular Signalling 18 (9), S. 1515 - 1527 (2006)

Thussbas, C.; Nahrig, J.; Streit, S.; Bange, J.; Kriner, M.; Kates, R.; Ulm, K.; Kiechle, M.; Hoefler, H.; Ullrich, A. et al.; Harbeck, N.: FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. Journal of Clinical Oncology 24 (23), S. 3747 - 3755 (2006)

Streit, S.; Mestel, D. S.; Schmidt, M.; Ullrich, A.; Berking, C.: FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients. British Journal of Cancer 94 (12), S. 1879 - 1886 (2006)

Streit, S.; Bange, J.; Fichtner, A.; Ihrler, S.; Issing, W.; Ullrich, A.: Involvement of the FGFr4 Arg388 allele in head and neck squamous cell carcinoma. International Journal of Cancer 111 (2), S. 213 - 217 (2004)

Fischer, O. M.; Streit, S.; Hart, S.; Ullrich, A.: Beyond Herceptin and Gleevec. Current Opinion in Chemical Biology 7 (4), S. 490 - 495 (2003)

Thussbas, C.; Nahrig, J.; Streit, S.; Bange, J.; Kates, R.; Ulm, K.; Kiechle, M.; Hoefler, H.; Ullrich, A.; Harbeck, N.: FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. ASCO Annual Meeting, 2006. Meeting Abstracts, S. 34S - 34S (2006)

Streit, S.: Relevanz von genetischen Determinanten für die Progression von Krebs. Dissertation, Technische Universität, München (2004)